The Perfect Recipe: Driving Sustainability, Flexibility, Quality, and Innovation in Cell and Gene Therapy
What is the perfect recipe that delivers the maximum result?
read morePeople & Career | News |
What is the perfect recipe that delivers the maximum result?
read moreWorking in a Biotech Manufacturing Organization means joining a team of talented professionals focused on innovation, continuous growth, and a shared mission to improve lives.
read moreAnemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to 12th International mRNA Health Conference 2024 in Boston, MA
read moreAnemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to 1st Annual Meeting AMM ASCENT in Boston, MA
read moreAnemocyte offers plasmid DNA (pDNA) manufacturing covering R&D, High Quality and GMP needs providing solutions that support every stage of therapy development while ensuring rigorous quality and traceability.
read moreAnemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to European Society of Gene & Cell Therapy 2024 in Rome, Italy
read moreQuality assurance (QA) is crucial in the manufacturing of plasmid DNA (pDNA), a key component in gene therapy, vaccine development, genome editing, and synthetic biology.
read moreAnemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to Cell & Gene Meeting on the Mesa in Phoenix, Arizona
read moreAnemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to CPHI Milan 2024
read moreDiscover the pivotal role of plasmid DNA sequencing in advancing gene therapy. Learn how this groundbreaking technology is driving the development of novel treatments and shaping the future of biomedicine.
read moreAnemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to ATE24 Lisbon, Portugal
read moreAnemocyte S.r.l. Single Shareholder Private Limited-Liability Company
Via R. Lepetit, 34 21040 Gerenzano (VA) Italy | Ph: +39 02 99372311 – Fax: +39 02 99372313 | VAT number: 12914940155 | Share capital € 530.000,00 fully paid | R.E.A. 276961